Publication:
Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R

dc.bibliographiccitation.issue21
dc.bibliographiccitation.journalBlood
dc.bibliographiccitation.volume124
dc.contributor.authorSchanz, Julie
dc.contributor.authorBraulke, Friederike
dc.contributor.authorMufti, Ghulam J.
dc.contributor.authorCrisa, Elena
dc.contributor.authorKulasekararaj, Austin
dc.contributor.authorNachtkamp, Kathrin
dc.contributor.authorGerming, Ulrich
dc.contributor.authorSchmitz, Stephan A.
dc.contributor.authorHaas, Peter
dc.contributor.authorLuebbert, Michael
dc.contributor.authorMueller-Thomas, Catharina
dc.contributor.authorGoetze, Katharina S.
dc.contributor.authorPlatzbecker, Uwe
dc.contributor.authorNolte, Florian
dc.contributor.authorHofmann, Wolf-Karsten
dc.contributor.authorHaase, Detlef
dc.date.accessioned2018-11-07T09:31:27Z
dc.date.available2018-11-07T09:31:27Z
dc.date.issued2014
dc.identifier.isi000349233801082
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/31537
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherAmer Soc Hematology
dc.publisher.placeWashington
dc.relation.conference56th Annual Meeting of the American-Society-of-Hematology
dc.relation.eventlocationSan Francisco, CA
dc.relation.issn1528-0020
dc.relation.issn0006-4971
dc.titleClinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R
dc.typeconference_abstract
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections